EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Fractional accumulative calibration‐free odds (f‐aCFO) design for delayed toxicity in phase I clinical trials

Jialu Fang, Guosheng Yin iD

Statistics in Medicine · 2024

DOI: 10.1002/sim.10127 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Statistics in Medicine, 2024. Verfasst von Jialu Fang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Statistics and Actuarial Science, The University of Hong Kong, Hong Kong, China. Hauptthemen laut MEDLINE: Clinical Trials, Phase I as Topic, Computer Simulation. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The calibration‐free odds (CFO) design has been demonstrated to be robust, model‐free, and practically useful but faces challenges when dealing with late‐onset toxicity. The emergence of the time‐to‐event (TITE) method and fractional method leads to the development of TITE‐CFO and fractional CFO (fCFO) designs to accumulate delayed toxicity. Nevertheless, existing CFO‐type designs have untapped potential because they primarily consider dose information from the current position and its two neighboring positions. To incorporate information from all doses, we propose the accumulative CFO (aCFO) design by utilizing data at all dose levels similar to a tug‐of‐war game where players distant from the center also contribute their strength. This approach enhances full information utilization while still preserving the model‐free and calibration‐free characteristics. Extensive simulation studies demonstrate performance improvement over the original CFO design, emphasizing the advantages of incorporating information from a broader range of dose levels. Furthermore, we propose to incorporate late‐onset outcomes into the TITE‐aCFO and f‐aCFO designs, with f‐aCFO displaying superior performance over existing methods in both fixed and random simulation scenarios. In conclusion, the aCFO and f‐aCFO designs can be considered robust, efficient, and user‐friendly approaches for conducting phase I trials without or with late‐onsite toxicity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Clinical Trials, Phase I as TopicComputer SimulationHumansResearch DesignDose-Response Relationship, DrugCalibrationDrug-Related Side Effects and Adverse ReactionsModels, StatisticalTime Factors

Stichwörter der Autor:innen

Bayesian designdose‐finding triallate‐onset toxicityodds ratiophase I trial

Autor:innen und Institutionen

  • Department of Statistics and Actuarial Science, The University of Hong Kong, Hong Kong, China.

ORCID-Profile: Guosheng Yin

Zitieren

APA

Fang, J., & Yin, G. (2024). Fractional accumulative calibration‐free odds (f‐aCFO) design for delayed toxicity in phase I clinical trials. Statistics in Medicine. https://doi.org/10.1002/sim.10127

Vancouver

Fang J, Yin G. Fractional accumulative calibration‐free odds (f‐aCFO) design for delayed toxicity in phase I clinical trials. Statistics in Medicine. 2024. doi:10.1002/sim.10127

BibTeX
@article{Fang2024,
  author = {Fang, Jialu and Yin, Guosheng},
  title = {Fractional accumulative calibration‐free odds (f‐aCFO) design for delayed toxicity in phase I clinical trials},
  journal = {Statistics in Medicine},
  year = {2024},
  doi = {10.1002/sim.10127}
}
Kostenlos starten →